Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05800756
Status:
RECRUITING
Last Update Posted:
2023-04-06
First Post:
2023-03-23
Brief Title:
Pyrotinib Combined With TrastuzumabDalpiciclib and Letrozole for HRHER2 Breast Cancer
Sponsor:
Yantai Yuhuangding Hospital
Organization:
Yantai Yuhuangding Hospital
Organization Data
Organization:
Yantai Yuhuangding Hospital
Class:
OTHER
Study ID:
2022-080
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yantai Yuhuangding Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jiangsu Hengrui Pharmaceutical Co Ltd | INDUSTRY |